Drug efficacy
Preclinical in vivo drug efficacy studies to evaluate therapeutic response, dose- response relationships and treatment outcomes in relevant disease models.
Preclinical drug efficacy overview
Evaluating therapeutic efficacy is a critical step in preclinical drug development. At IVRS, we assess drug candidates in relevant in vivo disease models to characterize therapeutic response, dose-response relationships and treatment outcomes. Our studies support the selection of effective doses and provide robust data for informed drug development decisions.
From dose optimization and PK/PD studies to therapeutic response assessment, IVRS provides preclinical drug efficacy services using relevant in vivo disease models. We also support the evaluation of novel drug delivery systems to generate robust data for informed treatment and development decisions.
Dose optimization
Determine effective dose ranges using relevant preclinical in vivo models and dose- response studies.
PK/PD assessment
Characterize drug exposure and pharmacological response to support dose selection and treatment strategies.
Mechanism of action
Assess drug interactions with molecular targets and biological pathways to understand therapeutic effects.
Therapeutic efficacy
Evaluate drug candidates alone or in combination to quantify therapeutic response in relevant in vivo disease models.
Key capabilities
- Dose optimization
- PK / PD assessment
- Mechanism of action
- Therapeutic efficacy
In vivo research services
Preclinical in vivo capabilities
01
In vivo imaging
Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.
Read more →
02
Drug validation
Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.
Read more →
03
Drug efficacy
In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.
Read more →
04
Biodistribution studies
Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.
Read more →
05
Toxicology assessment
Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.
Read more →
06
Preclinical study design
Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.
Read more →
Engage with us for journey to success
Do you want to learn more about our work and how we can help you?